Ebit Alterar Data
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Arrowhead Research USD -141.26M 182.07M 2026-03
Astellas Pharma JPY 185.36B 136.79B 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Celltrion KRW 13.41B 1.33B 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Exelixis USD 251.34M 15.43M 2026-03
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Kangmei Pharma CNY -12.72M 13.97M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Moderna USD -815M 573M 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.73B 549M 2026-06
Omeros USD -48.15M 7.25M 2023-09
OPKO Health USD -50.02M 11.7M 2026-03
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -173K 990K 2025-12
Pfizer USD -180M 5.16B 2026-06
Pharma Mar EUR -1.4M 2.03M 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Qiagen NV USD 96.88M 25M 2026-03
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06
Zealand Pharma A/S -389M 318.05M 2026-03
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03